Lindsay T. McDonald

Lindsay T. McDonald

Auto-generated profile, based on publicly available information

Lindsay T. McDonald

Veterans Health Administration, Eastern Colorado Health Care System, Rocky Mountain Regional Veterans Affairs Medical Center (RMRVAMC) , Aurora, CO 80045, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2010 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
SRSridhar Rao
Sridhar Rao
SZShao Zhen
Shao Zhen
SRSergei Roumiantsev
Sergei Roumiantsev
LMLindsay T. McDonald
Lindsay T. McDonald
GYGuo-Cheng Yuan
Guo-Cheng Yuan
SOStuart H. Orkin
Stuart H. Orkin
Murine embryonic stem (ES) cells are defined by continuous self-renewal and pluripotency. A diverse repertoire of protein isoforms arising from alternative splicing is expressed in ES cells without defined biological roles. Sall4, a transcription factor essential for pluripotency, exists as two isoforms (Sall4a and Sall4b). Both isoforms can form homodimers and a heterodimer with each other, and each can interact with Nanog. By genomewide location analysis, we determined that Sall4a and Sall4b have overlapping, but not identical binding sites within the ES cell genome. In addition, Sall4b, but not Sall4a, binds preferentially to highly expressed loci in ES cells. Sall4a and Sall4b binding sites are distinguished by both epigenetic marks at target loci and their clustering with binding sites of other pluripotency factors. When ES cells expressing a single isoform of Sall4 are generated, Sall4b alone could maintain the pluripotent state, although it could not completely suppress all differentiation markers. Sall4a and Sall4b collaborate in maintenance of the pluripotent state but play distinct roles. Our work is novel in establishing such isoform-specific differences in ES cells.

9 April 2019 in Frontiers in Psychiatry
Verified
Journal Article
Open access
PDF file
RKRyan R. Kelly
Ryan R. Kelly
LMLindsay T. McDonald
Lindsay T. McDonald
NJNathaniel R. Jensen
Nathaniel R. Jensen
SSSara J. Sidles
Sara J. Sidles
ALAmanda C. LaRue
Amanda C. LaRue
The significant biochemical and physiological effects of psychological stress are beginning to be recognized as exacerbating common diseases, including osteoporosis. This review discusses the current evidence for psychological stress-associated mental health disorders as risk factors for osteoporosis, the mechanisms that may link these conditions, and potential implications for treatment. Traditional, alternative, and adjunctive therapies are discussed. This review is not intended to provide therapeutic recommendations, but, rather, the goal of this review is to delineate potential interactions of psychological stress and osteoporosis and to highlight potential multi-system implications of pharmacological interventions. Review of the current literature identifies several potentially overlapping mechanistic pathways that may be of interest (e.g., glucocorticoid signaling, insulin-like growth factor signaling, serotonin signaling) for further basic and clinical research. Current literature also supports the potential for cross-effects of therapeutics for osteoporosis and mental health disorders. While studies examining a direct link between osteoporosis and chronic psychological stress are limited, the studies reviewed herein suggest that a multi-factorial, personalized approach should be considered for improved patient outcomes in populations experiencing psychological stress, particularly those at high-risk for development of osteoporosis.

1 July 2018 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
PDF file
LMLindsay T. McDonald
Lindsay T. McDonald
MZMichael R. Zile
Michael R. Zile
YZYuhua Zhang
Yuhua Zhang
ALAn O. Van Laer
An O. Van Laer
CBCatalin F. Baicu
Catalin F. Baicu
ABAmy D. Bradshaw
Amy D. Bradshaw
Myocardial fibrosis and the resultant increases in left ventricular stiffness represent pivotal consequences of chronic pressure overload (PO) that impact both functional capacity and the rates of morbid and mortal events. However, the time course and cellular mechanisms that underlie PO-induced fibrosis have not been completely defined. Secreted protein acidic and rich in cysteine (SPARC) is a matricellular protein that has been shown to be required for insoluble collagen deposition and increased myocardial stiffness in response to PO in mice. As macrophages are associated with increases in fibrillar collagen, the hypothesis that macrophages represent a source of increased SPARC production in the PO myocardium was tested. The time course of changes in the myocardial macrophage population was compared with changes in procollagen type I mRNA, production of SPARC, fibrillar collagen accumulation, and diastolic stiffness. In PO hearts, mRNA encoding collagen type I was increased at 3 days, whereas increases in levels of total collagen protein did not occur until 1 wk and were followed by increases in insoluble collagen at 2 wk. Increases in muscle stiffness were not detected before increases in insoluble collagen content (>1 wk). Significant increases in myocardial macrophages that coincided with increased SPARC were found but did not coincide with increases in mRNA encoding collagen type I. Furthermore, immunohistochemistry and flow cytometry identified macrophages as a cellular source of SPARC. We conclude that myocardial macrophages play an important role in the time-dependent increases in SPARC that enhance postsynthetic collagen processing, insoluble collagen content, and myocardial stiffness and contribute to the development of fibrosis. NEW & NOTEWORTHY Myocardial fibrosis and the resultant increases in left ventricular and myocardial stiffness represent pivotal consequences of chronic pressure overload. In this study a murine model of cardiac fibrosis induced by pressure overload was used to establish a time course of collagen expression, collagen deposition, and cardiac macrophage expansion.

1 January 2015 in World Journal of Stem Cells
Verified
Journal Article
Open access
YXYing Xiong
Ying Xiong
LMLindsay T McDonald
Lindsay T McDonald
DRDayvia L Russell
Dayvia L Russell
RKRyan R Kelly
Ryan R Kelly
KWKatie R Wilson
Katie R Wilson
ALAmanda C. LaRue
Amanda C. LaRue
Hematopoietic stem cell-derived adipocytes and fibroblasts in the tumor microenvironment

1 May 2015 in Neoplasia
Verified
Journal Article
Open access
LMLindsay T. McDonald
Lindsay T. McDonald
DRDayvia L. Russell
Dayvia L. Russell
RKRyan R. Kelly
Ryan R. Kelly
YXYing Xiong
Ying Xiong
AMAnjan Motamarry
Anjan Motamarry
ALAmanda C. LaRue
Amanda C. LaRue
Targeting the tumor microenvironment is critical toward improving the effectiveness of cancer therapeutics. Cancer-associated fibroblasts (CAFs) are one of the most abundant cell types of the tumor microenvironment, playing an important role in tumor progression. Multiple origins for CAFs have been proposed including resident fibroblasts, adipocytes, and bone marrow. Our laboratory previously identified a novel hematopoietic stem cell (HSC) origin for CAFs; however, the functional roles of HSC-derived CAFs (HSC-CAFs) in tumor progression have not yet been examined. To test the hypothesis that HSC-CAFs promote tumor progression through contribution to extracellular matrix (ECM) and paracrine production of pro-angiogenic factors, we developed a method to isolate HSC-CAFs. HSC-CAFs were profiled on the basis of their expression of hematopoietic and fibroblastic markers in two murine tumor models. Profiling revealed production of factors associated with ECM deposition and remodeling. Functional in vivo studies showed that co-injection of HSC-CAFs with tumor cells resulted in increased tumor growth rate and significantly larger tumors than tumor cells alone. Immunohistochemical studies revealed increased blood vessel density with co-injection, demonstrating a role for HSC-CAFs in tumor vascularization. Mechanistic in vitro studies indicated that HSC-CAFs play a role in producing vascular endothelial growth factor A and transforming growth factor-β1 in endothelial tube formation and patterning. In vitro and in vivo findings suggest that HSC-CAFs are a critical component of the tumor microenvironment and suggest that targeting the novel HSC-CAF may be a promising therapeutic strategy.

1 January 2018 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
AAAdam W. Akerman
Adam W. Akerman
RSRobert E. Stroud
Robert E. Stroud
RBRyan W. Barrs
Ryan W. Barrs
RGR. Tyler Grespin
R. Tyler Grespin
LMLindsay T. McDonald
Lindsay T. McDonald
JRJean Marie Ruddy
Jean Marie Ruddy